Guideline Content Index
A comparison table/index with various guidelines (GRI, TCFD, SASB, Environmental Report) is also disclosed in the Environmental Report (P137~).
- What is “Health & Well-being” in Kirin Group?
- Ensuring food safety and security
- Ensuring stable supply, safety and reliability as a pharmaceutical company
- Provide pharmaceuticals for Unmet Medical Needs
- Support for maintaining the immune system
- Ensuring occupational health and safety
- Support for the prevention of non-communicable diseases
- Implementation of health management
- Helping to improve the performance of brain function and prevent decline
- Improvement of access to nutrition
- Sustainable use of biological resources
- Sustainable use of water resources
- Sustainable recycling of containers and packaging
- Overcoming climate change
- Kirin Group's Environmental Vision 2050
- Message from Top Management
- Vision / Policies / Structure
- Environmental management and CSV
- Our Holistic Approach
- Third-Party Evaluations of environment
- Domestic sale outline report(Monthly)
- Domestic Monthly sales report(Archive)
- Domestic Alcohol market data(Year)
- Market data of Australia, Myanmar, and Philippines (Year)
- Beer consumption by region(Year)
- Beer consumption by country(Year)
- Domestic Soft drink market data(Year)
- Domestic Wine market data(Year)
- Message from Top Management
- Interview with the Chief Financial Officer
- CSV Stories CASE1 Pharmaceuticals business
- CSV Stories CASE2 Businesses bridging Pharmaceuticals and Food & Beverages
- CSV Stories CASE3 Community Engagement
- CSV Stories CASE4 The Environment
- CSV Stories CASE5 A Responsible Alcohol Producer
- Discussion with Management
- Interview with an Outside Director
- Financial and Non-financial Highlights
- Past and Present
- Message from Top Management
- Discussion with Management, Part1
- Discussion with Management, Part2
- Interview with an Outside Director
- CASE1 Kirin Ichiban Shibori Relaunch and Craft Beer Market Development
- CASE2 Pharmaceuticals for Worldwide Markets
- CASE3 Lactococcus lactis strain Plasma Stars in New Products
- CASE4 Advanced High-Efficiency Facilities at Myanmar Brewery
- History of the Kirin Group
- The Kirin Group Today
- Overview by segment and business for fiscal 2017
- Management's discussion & analysis